Sex hormone binding globulin and free levonorgestrel index in the first week after insertion of Norplant® implants

被引:10
作者
Alvarez, F
Brache, V
Tejada, AS
Cochon, L
Faundes, A
机构
[1] PROFAMILIA, Biomed Res Dept, Santo Domingo, Dominican Rep
[2] Univ Estadual Campinas, Dept Obstet & Gynecol, BR-13081970 Campinas, SP, Brazil
关键词
Norplant((R)) implant; levonorgestrel serum level; sex hormone binding globulin;
D O I
10.1016/S0010-7824(98)00102-4
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Levonorgestrel has nn inhibitory effect on sex hormone binding globulin (SHBG). This decrease in SHBG lends to an increase in the free levonorgestrel index (FLI), which has a stronger biological effect. The interaction between serum levels of levonorgestrel and SHBG in long-term users of Norplant(R) implants has been described. This study was designed to understand the same interaction immediately after the insertion of the implants, in a group of 16 women, sampled at 0 and 6 h and at 1, 3, and 7 days after Norplant implant insertion. Peak serum levonorgestrel levels were achieved at 24 h after insertion, remaining stable on day 3 and decreasing by >10% by day 7. SHBG did not change during the first 24 h, but decreased by 19% and 60% on days 3 and 7, respectively. FLI more than doubled from day 1 to day 7 after insertion. The large decrease in SHBG and doubling of FLI is not followed by a similar reduction in levonorgestrel, which is hard to explain without an increase in the release rate of the steroid from the capsule. (C) 1998 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:211 / 214
页数:4
相关论文
共 14 条
[1]   THE INTERACTION BETWEEN SEX-HORMONE BINDING GLOBULIN AND LEVONOR-GESTREL RELEASED FROM NORPLANT, AN IMPLANTABLE CONTRACEPTIVE [J].
AFFANDI, B ;
CEKAN, SZ ;
BOONKASEMSANTI, W ;
SAMIL, RS ;
DICZFALUSY, E .
CONTRACEPTION, 1987, 35 (02) :135-145
[2]   OVARIAN-FUNCTION DURING USE OF A LEVONORGESTREL-RELEASING IUD [J].
BARBOSA, I ;
BAKOS, O ;
OLSSON, SE ;
ODLIND, V ;
JOHANSSON, EDB .
CONTRACEPTION, 1990, 42 (01) :51-66
[3]  
Brache V., 1992, Advances in Contraception, V8, P319, DOI 10.1007/BF02042590
[4]   THE INTERACTION BETWEEN SEX-HORMONE BINDING GLOBULIN AND LEVONORGESTREL RELEASED FROM VAGINAL RINGS IN WOMEN [J].
CEKAN, SZ ;
JIA, M ;
LANDGREN, BM ;
DICZFALUSY, E .
CONTRACEPTION, 1985, 31 (04) :431-439
[5]  
JIA M C, 1992, Advances in Contraception, V8, P33, DOI 10.1007/BF01849346
[6]   PHARMACOKINETICS OF LEVONORGESTREL IN 12 WOMEN WHO RECEIVED A SINGLE ORAL DOSE OF 0.15 MG LEVONORGESTREL AND, AFTER A WASH-OUT PHASE, THE SAME DOSE DURING ONE TREATMENT CYCLE [J].
KUHNZ, W ;
ALYACOUB, G ;
FUHRMEISTER, A .
CONTRACEPTION, 1992, 46 (05) :443-454
[7]   PHARMACOKINETIC AND PHARMACODYNAMIC EFFECTS OF VAGINAL RINGS RELEASING LEVONORGESTREL AT A RATE OF 27 MU-G/24 HOURS - A PILOT-STUDY [J].
LANDGREN, BM ;
AEDO, AR ;
JOHANNISSON, E ;
CEKAN, SZ .
CONTRACEPTION, 1994, 49 (02) :139-150
[8]   STEROID RELEASE FROM SILASTIC CAPSULES AND RODS [J].
NASH, HA ;
ROBERTSON, DN ;
YOUNG, AJM ;
ATKINSON, LE .
CONTRACEPTION, 1978, 18 (04) :367-394
[9]   CHANGES IN SERUM LEVELS OF SHBG, ENDOGENOUS LIGANDS AND LEVONORGESTREL INDUCED BY ETHINYLESTRADIOL IN NORPLANT USERS [J].
NOE, G ;
PAVEZ, M ;
CROXATTO, HB .
CONTRACEPTION, 1992, 45 (03) :187-201
[10]   PLASMA-LEVELS OF LEVONORGESTREL AND FREE LEVONORGESTREL INDEX IN WOMEN USING NORPLANT IMPLANTS OR 2 COVERED RODS (NORPLANT-2) [J].
OLSSON, SE ;
ODLIND, V ;
JOHANSSON, EDB ;
NORDSTROM, ML .
CONTRACEPTION, 1987, 35 (03) :215-228